![Rare disease day](https://i2.wp.com/www.delveinsight.com/blog/wp-content/uploads/2019/02/rare-disease.png?fit=1360%2C2657&ssl=1)
DelveInsight Blog
Rare Disease Day
Feb 28, 2019 | Reading Time: < 1 minute
![Rare disease day](https://i2.wp.com/www.delveinsight.com/blog/wp-content/uploads/2019/02/rare-disease.png?fit=1360%2C2657&ssl=1)
Related Article
![wainua-for-hattr-pn-treatment wainua-for-hattr-pn-treatment](https://assets.delveinsight.com/blog/wp-content/uploads/2024/01/05163324/wainua-for-hattr-pn-treatment.png)
Wainua – The Only Approved Medicine for hATTR-PN Treatment
Ionis Pharmaceuticals and AstraZeneca concluded the year 2023 on a positive note as they received the eagerly awaited approval from the FDA for their transthyretin amyloidosis (ATTR) medication, Wainua. In particular, the agency approved the use of the ligand-conjugated antisense oligonucleotide (LICA) medication f...
Find More![top-rare-eye-diseases top-rare-eye-diseases](https://assets.delveinsight.com/blog/wp-content/uploads/2023/10/16142117/top-rare-eye-diseases.webp)
The Hidden World of Vision: Exploring the Top 5 Rare Eye Diseases
Rare diseases affect a larger population than cancer and AIDS combined, with over 7,000 distinct conditions impacting more than 300 million globally. Approximately 1 in 10 individuals are affected by a rare disease, and it often requires several years to receive an accurate diagnosis, averaging around 4.8 years. Ap...
Find More![Gene Therapies for Dystrophic Epidermolysis Bullosa Gene Therapies for Dystrophic Epidermolysis Bullosa](https://assets.delveinsight.com/blog/wp-content/uploads/2023/06/16151304/Gene-Therapies-for-Dystrophic-Epidermolysis-Bullosa.png)
Will The Burgeoning Gene Therapies Make a Difference in Dystrophic Epidermolysis Bullosa Patients’ Lives?
Dystrophic epidermolysis bullosa (DEB) is an inherited disorder caused by changes in the COL7A1 gene. In this rare condition, blisters form on the skin and the moist inner lining of some organs and body cavities. Depending upon the nature of the inheritance pattern, dystrophic epidermolysis bullosa is divided into ...
Find MoreEditor's Pick
Newsletter/Whitepaper
Recent Article
ASCO Conference 2024
![ASCO 2023 ASCO 2023](https://assets.delveinsight.com/img/events/american-society-of-clinical-oncology-conference-2024.png)
Live Coverage of ASCO 2024 Visit Now for Real-Time Insights and Analytical, Impactful Updates!